Publication | Open Access
The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer
11
Citations
26
References
2017
Year
MedicineDrug DiscoveryMechanism Of ActionAnti-cancer AgentNovel BenzothiazinonesDrug DevelopmentPharmacologyPharmaceutical ChemistryBiomolecular EngineeringOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1